Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Nature Reviews. Clinical Oncology|December 17, 2009
Genomic markers for decision making: what is preventing us from using markers?Vicky M Coyle, Patrick G JohnstonCurrent Opinion in Pharmacology|June 6, 2006
Predicting the outcome of chemotherapy for colorectal cancerWendy L Allen, Vicky M Coyle, Patrick G JohnstonPersonalized Medicine|May 24, 2018
Predictive and prognostic markers in colorectal cancerRichard C Turkington, Vicky M Coyle, Patrick G Johnston, et al.Current Colorectal Cancer Reports|June 25, 2016
Molecular Subtypes and Personalized Therapy in Metastatic Colorectal CancerDonna M Graham, Vicky M Coyle, Richard D Kennedy, et al.Tumori|December 14, 2012
Metastatic melanoma: a regional review and future directionsKhurum H Khan, Rebecca B Goody, Hassan Hameed, et al.Molecular Cancer Therapeutics|June 6, 2012
Pharmacogenomic profiling and pathway analyses identify MAPK-dependent migration as an acute response to SN38 in p53 null and p53-mutant colorectal cancer cellsWendy L Allen, Richard C Turkington, Leanne Stevenson, et al.European Journal of Cancer (Oxford, England : 1990)|May 14, 2023
Circulating tumour DNA kinetics in recurrent/metastatic head and neck squamous cell cancer patientsKirsty Taylor, Jinfeng Zou, Marcos Magalhaes, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2008
Clinical determinants of response to irinotecan-based therapy derived from cell line modelsWendy L Allen, Vicky M Coyle, Puthen V Jithesh, et al.Molecular Cancer Therapeutics|October 27, 2011
A systems biology approach identifies SART1 as a novel determinant of both 5-fluorouracil and SN38 drug resistance in colorectal cancerWendy L Allen, Leanne Stevenson, Vicky M Coyle, et al.British Journal of Cancer|May 14, 2022
A first-in-human Phase I dose-escalation trial of the novel therapeutic peptide, ALM201, demonstrates a favourable safety profile in unselected patients with ovarian cancer and other advanced solid tumoursAya El Helali, Ruth Plummer, Gordon C Jayson, et al.Pageof 2